Quotient Therapeutics
Geoffrey von Maltzahn is a highly experienced and accomplished individual who has co-founded and led several groundbreaking life sciences companies in various capacities. With a background in Biomedical Engineering and Chemical Engineering, Geoffrey has been instrumental in driving innovation in fields such as gene therapy, microbiome therapeutics, and biomedicines. As a General Partner at Flagship Pioneering and Founding CEO/C-level executive at multiple companies, Geoffrey has played a significant role in advancing transformative technologies and developing novel treatments to address a wide range of diseases and health challenges.
This person is not in any offices
Quotient Therapeutics
Our Somatic Genomics platform unveils a new universe of genetic variation to create transformational medicines. Learn more at Quotient-Tx.com